| Autor: |
Комитова, Р., Кеворкян, А., Учикова, Е., Владов, К. |
| Zdroj: |
General Medicine / Obsta Medicina; 2019, Vol. 21 Issue 5, p71-79, 9p |
| Abstrakt: |
Thrifty five years after establishing the causal link between human papilloma viruses (HPVs) and cervical cancer and 12 years after creating the first HPV vaccine sufficient data had been accumulated that evaluate the changes of HPV spread, the associated precancers, as well as the vaccine influence over these changes. In addition, studies had confirmed HPV role in the etiology and pathogenesis of other cancers – anogenital, oropharyngeal and cutaneous, among men and women. According to the updated World Health Organization (WHO) recommendations, two doses HPV vaccine are recommended for girls aged 9-14 years in every country where the prevention of cervical cancer is a public health’s priority and the introduction of the vaccine is feasible and sustainable. If financial security is available, WHO also advises on vaccinating other age groups (girls > 15 years) and boys. The expansion of the vaccine coverage should not be at the expense of the classical screening programs for women. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
